Manjari Tripathi

Manjari Tripathi

Auto-generated profile, based on publicly available information

Manjari Tripathi

Dept. of Neurology, All India Institute of Medical Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
PMPranav Mirpuri
Pranav Mirpuri
PCP. Prarthana Chandra
P. Prarthana Chandra
RSRaghu Samala
Raghu Samala
MAMohit Agarwal
Mohit Agarwal
RDRamesh Doddamani
Ramesh Doddamani
MTManjari Tripathi
Manjari Tripathi

23 February 2022 in Epilepsy & Behavior
Verified
Journal Article
Closed access
MKMukesh Kumar
Mukesh Kumar
BRBhargavi Ramanujam
Bhargavi Ramanujam
SBSatish Barki
Satish Barki
RDRekha Dwivedi
Rekha Dwivedi
DVDeepti Vibha
Deepti Vibha
MTManjari Tripathi
Manjari Tripathi

21 July 2020 in Physical and Engineering Sciences in Medicine
Verified
Journal Article
Closed access
PDF file
ABDUL QUAIYUM ANSARIABDUL QUAIYUM ANSARI
ABDUL QUAIYUM ANSARI
PSPriyanka Sharma
Priyanka Sharma
MTManjari Tripathi
Manjari Tripathi

28 June 2020 in Journal of Epilepsy Research
Verified
Journal Article
Open access
PDF file
JPJasmine Parihar
Jasmine Parihar
MTManjari Tripathi
Manjari Tripathi
RDRajinder K. Dhamija
Rajinder K. Dhamija
The end of the year 2019 was marked by novel coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) outbreak in China that rapidly spread to the rest of the world. While the involvement of the lower respiratory system causing pneumonia is identified as the primary target of the virus, extra-pulmonary manifestations, especially of the central nervous system, are also being increasingly reported. Previous research on Middle East respiratory syndrome coronavirus and SARS-CoV have shown neurological involvement in human coronavirus infections. While several cases of seizures have been reported in patients with coronavirus disease 2019 (COVID-19) patients, there is no specific data to suggest an association of COVID-19 with epilepsy. Epilepsy patients on immunosuppressive medications may have a higher risk of contracting the viral infection. There can be an indirect relation of COVID-19 to epilepsy as the viral infection is associated with fever in most COVID-19 cases, which can lower seizure threshold. Additionally, inadequate sleep and stress due to ongoing pandemic of coronavirus can be another trigger for seizure precipitation in epilepsy patients. Drug compliance, availability of antiepileptic drugs, and drug interactions with COVID-19 experimental drugs are major concerns in epilepsy patients. Adopting telemedicine services and the use of epilepsy helplines may be important in assisting epilepsy patients and ensuring that treatment continues uninterrupted.

1 September 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
RPRadhakrishna Pedapati
Radhakrishna Pedapati
RBRohit Bhatia
Rohit Bhatia
MSManeesh Shakywar
Maneesh Shakywar
AGAkash Gupta
Akash Gupta
SVSreenivas Vishnubhatla
Sreenivas Vishnubhatla
KPKameshwar Prasad
Kameshwar Prasad